You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 4, February 23, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Prognosis/ Outcomes
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Predictive Value of Elevated White Blood Cell Count in Patients With Preexisting Coronary Heart Disease

The Bezafibrate Infarction Prevention Study

Moti Haim, MD; Valentina Boyko, MSc; Uri Goldbourt, PhD; Alexander Battler, MD; Solomon Behar, MD

Arch Intern Med. 2004;164:433-439.

Background  Inflammation is implicated in the pathogenesis of atherosclerosis and acute coronary syndromes. White blood cell (WBC) count increases during infections and inflammatory illnesses and has been shown to predict coronary heart disease (CHD) independent of traditional cardiovascular risk factors. This apparent association may reflect a relationship between the WBC count and other coronary risk factors. Studies in patients with CHD are scarce and give conflicting results. The aim of the present study was to investigate the association between WBC count and subsequent coronary events and total mortality in a large cohort of patients with CHD.

Methods  We evaluated the relationship between WBC count and 6-year risk of coronary events and mortality in a large cohort of patients with chronic CHD who were enrolled in a secondary prevention study of bezafibrate.

Results  In univariate analysis, WBC count was associated with an elevated 6-year risk of myocardial infarction, cardiac death, and total mortality. On multivariate adjustment, the positive association with risk of myocardial infarction and cardiac death was eliminated, but WBC count remained predictive of total mortality: relative risk, 1.47; 95% confidence interval, 1.13 to 1.92, in the upper tertile of WBC count (as compared with the lowest). For every 1000/µL increase in WBC count, risk of total death increased by 6% (relative risk, 1.06; 95% confidence interval, 1.03-1.10).

Conclusions  Elevated WBC count in patients with CHD was associated with higher long-term risk of all-cause mortality. This excess risk of mortality was not due to cardiac causes.


From the Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel (Drs Haim and Battler), and Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, Israel (Ms Boyko and Drs Goldbourt and Behar), both affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Psyllium Fiber Supplementation on C-Reactive Protein: The Trial to Reduce Inflammatory Markers (TRIM)
King et al.
Ann Fam Med 2008;6:100-106.
ABSTRACT | FULL TEXT  

Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease
Lavi et al.
Circulation 2007;115:2621-2627.
ABSTRACT | FULL TEXT  

Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?
Horne et al.
J Am Coll Cardiol 2005;45:1638-1643.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.